(Adds adjusted profit, background in paragraphs 3-7) COPENHAGEN, Aug 4 (Reuters) – Novo Nordisk, the maker of weight-loss drug Wegovy, reported a second-quarter adjusted operating profit above
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
REUTERS SPORTS SCHEDULE AT 6:30 p.m. GMT/ 2:30 p.m. ET
Here are the top sports stories and upcoming coverage plans for Reuters text service as…
Exclusive-US weighs polysilicon price floor, tariffs to counter China in solar and chips
By Nichola Groom Aug 4 (Reuters) - The Trump administration is preparing to set a…
Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts
By Mariam Sunny and Mrinalika Roy Aug 4 (Reuters) - Pfizer reported better-than-expected second-quarter results…
